Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analogues. 2007

Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
Department of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ 86011-5698, USA.

To develop an understanding of the structure-activity relationships for the inhibition of orthopoxviruses by nucleoside analogues, a variety of novel chemical entities were synthesized. These included a series of pyrimidine 5-hypermodified acyclic nucleoside analogues based upon recently discovered new leads, and some previously unknown "double-headed" or "abbreviated" nucleosides. None of the synthetic products possessed significant activity against two representative orthopoxviruses; namely, vaccinia virus and cowpox virus. They were also devoid of significant activity against a battery of other DNA and RNA viruses. So far as the results with the orthopoxviruses and herpes viruses, the results may point to the necessity for nucleoside analogues 5'-phosphorylation for antiviral efficacy.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012328 RNA Viruses Viruses whose genetic material is RNA. RNA Rodent Viruses,RNA Rodent Virus,RNA Virus,Rodent Virus, RNA,Rodent Viruses, RNA,Virus, RNA,Virus, RNA Rodent,Viruses, RNA,Viruses, RNA Rodent
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018155 Orthopoxvirus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS. Camelpox virus,Horsepox virus,Raccoonpox virus,Skunkpox virus,Taterapox virus,Volepox virus,Camelpox viruses,Horsepox viruses,Orthopoxviruses,Raccoonpox viruses,Skunkpox viruses,Taterapox viruses,Volepox viruses,virus, Camelpox,virus, Horsepox,virus, Raccoonpox,virus, Skunkpox,virus, Taterapox,virus, Volepox

Related Publications

Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
July 2010, Nucleosides, nucleotides & nucleic acids,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
February 2009, Nucleosides, nucleotides & nucleic acids,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
August 1990, Journal of medicinal chemistry,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
June 2000, Bioorganic & medicinal chemistry,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
January 1998, Advances in experimental medicine and biology,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
April 1995, Molecular pharmacology,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
September 1994, Journal of medicinal chemistry,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
September 2017, Bioorganic & medicinal chemistry,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
July 2011, Antiviral chemistry & chemotherapy,
Xinying Zhang, and Adel Amer, and Xuesen Fan, and Jan Balzarini, and Johan Neyts, and Erik De Clercq, and Mark Prichard, and Earl Kern, and Paul F Torrence
May 2010, Beilstein journal of organic chemistry,
Copied contents to your clipboard!